| Document |
Document Title |
|
WO/1992/015546A1 |
Compounds and a method useful for protection of tissue cells in a mammalian body from irreversible damages due to lactic acidosis caused by oxygen deficiency. The protection is achieved by administering a compound having a cell membrane ...
|
|
WO/1992/015556A1 |
Described is a new method of preparing benzoyloxybenzenesulphonates from oxybenzenesulphonates and benzoic acid chlorides. The preparation is carried out in a solvent mixture consisting of water and an organic solvent chosen from the gro...
|
|
WO/1992/015555A2 |
Fluorinated alkene compounds useful for and methods of controlling nematodes, insects, and acarids that prey on agricultural crops. Polar compounds, for example, 3,4,4-trifluoro-3-butene-1-amine or 3,4,4-trifluoro-3-butenoic acid, are pa...
|
|
WO/1992/014738A1 |
This invention is a process for converting hydrocarbonaceous feeds, particularly lower alkanes, into their corresponding esters and optionally into various intermediates (such as alcohols) and optionally into liquid hydrocarbons. The hyd...
|
|
WO/1992/013532A2 |
A redox, hydrogen-acceptor compound, having utility in treating inflammation, is a 1,4-dioxonaphthalene or 1,4-diiminonaphthalene having either a 2,3-double bond, in which case there are 2 and 3-substituents, or a 2,3-single bond. Exampl...
|
|
WO/1992/014189A1 |
The invention provides novel photographic compositions comprising a propene isomer of formula (I) wherein A, B or E, each individually represent hydrogen, or an electron withdrawing group, selected for example from -CN, -NO2, -SO2R, -SO2...
|
|
WO/1992/013843A1 |
This invention relates to novel processes for synthesizing intermediates in the preparation of N-aryl and N-heteroarylamide inhibitors of the enzyme acyl coenzyme A: cholesterol acyltransferase (ACAT), and to novel intermediates used in ...
|
|
WO/1992/012709A1 |
A composition for use in inhibiting cell infection by an enveloped virus, by administering to an infection site, a therapeutically effective amount of a macrocyclic compound composed of aryl ring subunits connected one to another by ring...
|
|
WO/1992/012708A1 |
A pharmaceutical composition is disclosed for use in inhibiting blood coagulation in a human subject. The composition includes a macrocyclic compound composed of aryl ring subunits connected one to another by ring-attached bridge linkage...
|
|
WO/1992/012764A1 |
An improved aqueous film-forming foamable concentrate which is particularly useful for extinguishing flammable liquid fires. The preferred formulation contains (a) fluoroaliphatic amphoteric surfactant, preferably a fluorinated aminocarb...
|
|
WO/1992/008695A1 |
The invention concerns a method of preparing concentrated aqueous dispersions of the mono and/or di salts of $g(a)-sulphonic fatty acids by sulphonating saturated fatty acids, and/or fatty-acid mixtures, with sulphur trioxide, surface-ac...
|
|
WO/1992/009010A1 |
The invention provides novel photographic compositions comprising a propene isomer of formulae (I), wherein A, B or E, each individually represent hydrogen, or an electron withdrawing group, selected for example from -CN, -NO2, -SO2R, -S...
|
|
WO/1992/007926A1 |
The present invention relates to a process for manufacturing improved color surfactant agglomerates, particularly comprising methyl ester sulfonates, for use in detergent compositions, said process comprising sulfonation of methyl ester,...
|
|
WO/1992/007826A1 |
The present invention is directed to compounds of general formula (I), methods for using the compounds of formula (I), pharmaceutical compositions thereof, and processes for preparing the compounds. Formula (I) wherein X is oxygen or sul...
|
|
WO/1992/006935A1 |
A sulfonating agent represented by general formula (I) and a process for sulfonating an aromatic compound therewith, wherein R1 groups may be the same or different from each other and each represents C1 to C3 lower alkyl, n represents an...
|
|
WO/1992/006683A1 |
The present invention relates to a method of treating a retrovirus utilizing a compound of the formula (I): (R¿2?)¿n?R¿1?-Ar-X-Y-R(T¿1?)(T¿2?)¿m?. The present invention also relates to pharmaceutical compositions in which the activ...
|
|
WO/1992/006074A1 |
A photosensitive azo compound represented by general formula (I), wherein R?1¿ and R?2¿ may be the same or different from each other and each represents halogen, halogenated C¿1? to C¿6? alkyl, -NO¿2?, -SC=N, -C=N, -SO¿3?H, -C¿n?F...
|
|
WO/1992/005150A1 |
Disclosed are sulphonated octadienyl aryl ethers prepared by reacting with sulphonating agents, aryl ethers of formula (I) or (II), in which R?1¿ is an aliphatic hydrocarbon group with 8 carbon atoms and 2 double bonds, R?2¿ is hydroge...
|
|
WO/1992/004328A1 |
Compounds useful as antiviral agents against DNA-containing viruses, such as herpes group viruses, are disclosed. The compounds are represented by compounds of formula (1.0) and their pharmaceutically acceptable salts and solvates. Pharm...
|
|
WO/1992/002484A1 |
Compounds having anti-inflammatory and other activities are disclosed. The compounds are derived from diterpenes, aromatic heterocyclic compounds of the indole, indene, benzofuran and benzothiophene class and from polyacetates, diaminobe...
|
|
WO/1992/002487A1 |
Diamine compounds represented by general formula (I) and acid addition salts thereof, and a brain protecting agent containing the same, wherein R1 to R6 may be the same or different from one another and each represents hydrogen, halogen,...
|
|
WO/1992/000749A1 |
The oligomers of the present invention are polyureas, polycarbonates, polyesters or polyamides having a number average molecular weight of <10,000. These oligomers are water-soluble, have a rigid backbone with a predictable anion spacing...
|
|
WO/1992/000275A1 |
The description relates to a process for producing enantiomer-pure $g(a)-hydroxypropionoaldehyde derivatives of the general formula (I) in which: R¿1? is the substituent Q which may be a hydrocarbon radical interrupted by oxygen atoms, ...
|
|
WO/1991/018869A1 |
A phenyl 4-guanidinobenzoate derivative of general formula (I) and a pharmacologically acceptable acid addition salt thereof, each having an excellent protease inhibitor activity, wherein R1 represents hydrogen or halogen; R2 represents ...
|
|
WO/1991/018872A1 |
In the production of light-coloured pastes of $g(a)-sulpho fatty acid alkyl ester alkali metal salts by reacting fatty acid alkyl esters with gaseous SO�3?, followed by additional reaction in liquid phase and neutralization with aqueou...
|
|
WO/1991/018890A1 |
A compound of general formula I(a) and/or I(b) and/or I(c), in which R1 represents a methyl group or a group of the general formula -CH2.SO2.R2 or -CH2.SO2.NR2R3, in which each of R2 and R3 independently represents an alkyl, cycloalkyl o...
|
|
WO/1991/018873A1 |
In the production of highly concentrated pastes of $g(a)-sulpho fatty acid alkyl ester alkali metal salts by reacting fatty acid alkyl esters with gaseous SO�3?, followed by additional reaction in liquid phase and neutralization with a...
|
|
WO/1991/018870A1 |
In the production of highly concentrated pastes of $g(a)-sulpho fatty acid alkyl ester alkali metal salts by reacting fatty acid alkyl esters with gaseous SO�3?, followed by additional reaction in liquid phase and neutralization with a...
|
|
WO/1991/018874A1 |
In the production of light-coloured pastes of $g(a)-sulpho fatty acid alkyl ester alkali metal salts by reacting fatty acid alkyl esters with gaseous SO�3?, followed by additional reaction in liquid phase and neutralization with aqueou...
|
|
WO/1991/017987A1 |
Fused aryl phenol/pyridinol derivatives are disclosed as medicaments.
|
|
WO/1991/016297A1 |
Compounds of general formula (I) wherein X and Y are the same or different and are selected from the group consisting of SO3(-), -CO-, -C(O)O(-), -R4-C(O)O-, -NR3C(O)-, -R4O-, -R4OC(O)-, -R4- and -NC(O)-, R4 being -(CH2)m- where m is fro...
|
|
WO/1991/016299A1 |
A method for control of plant disease, especially fungus, using compounds of formula (I) and novel compounds within the class, wherein: A is C(=O)R, C(=O)OR1, C(=O)SR1, P(=O)QR2Q1R3; C(=O)NHR, SO2R5, SO2NR6R7; Q and Q1 are independently ...
|
|
WO/1991/016300A1 |
Light-coloured ester sulphonates are obtainable by the sulphonation of fatty acid low-alkyl esters and subsequent processing if fatty acid esters with a low oxo and unsaturated compound content are introduced into the sulphonation stage.
|
|
WO/1991/016320A1 |
Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid, pharmaceutical formulations thereof, methods for their preparation and their use in the treatment of viral infections, in particular influenza, are described.
|
|
WO/1991/015471A1 |
A process is disclosed for the isolation of an enantiomerically enriched alcohol from a first mixture of an enantiomerically enriched alcohol and an enantiomerically enriched ester. The process includes the steps of: (a) contacting the m...
|
|
WO/1991/015472A1 |
A process is disclosed for the separation of an enantiomerically enriched 1-tosyloxy-2-acyloxy-3-butene and an enantiomerically enriched 1-tosyloxy-2-hydroxy-3-butene from a first mixture containing both compounds. The process includes t...
|
|
WO/1991/015478A1 |
This invention relates to novel sulfonamides and their use as crop selective herbicides. Compounds of the instant invention have demonstrated excellent control of weeds coupled with corn safety.
|
|
WO/1991/015470A1 |
A process is disclosed for the isolation of an enantiomerically enriched alcohol from a first mixture of an enantiomerically enriched 1-arylsulfonate-2-hydroxy-3-butene and an enantiomerically enriched 1-arylsulfonate-2-acyloxy-3-butene....
|
|
WO/1991/015469A1 |
A process is disclosed for the isolation of an enantiomerically enriched ester from a first mixture of an enantiomerically enriched alcohol and an enantiomerically enriched ester, said process comprising the steps of: (a) contacting said...
|
|
WO/1991/015290A1 |
The present invention relates to a surfactant having general formula (I) where R is a hydrocarbon containing 4-6 carbon atoms; r is 0 or 1; Y is an alkylene group having 1-3 carbon atoms and optionally containing a hydroxyl group; m1 and...
|
|
WO/1991/015289A1 |
The present invention relates to a surfactant having general formula (I) in which R3 is C8-12 alkyl, R4 is C2-6 alkyl, A is an alkyleneoxy group derived from an alkylene oxide having 2-3 carbon atoms, p has an average number of from 2 to...
|
|
WO/1991/015474A1 |
Novel highly water-soluble peroxyacid bleach precursor compounds are described of general formula (I), where R is methyl or ethyl, A is a C2-C6 alkylene, or phenylene group and Y is a sulphate, sulphonate quaternary ammonium or morpholin...
|
|
WO/1991/013864A1 |
Naphthalene sulphonic acids with a high content of beta-naphthalene sulphonic acid are obtained by reacting naphthalene with gaseous sulphur trioxide mixed with an inert gas, followed by isomerization of the raw sulphonation product.
|
|
WO/1991/013863A1 |
In a method for preparing 3-nitrobenzene sulphonic acid chloride from nitrobenzene and chlorosulphonic acid, nitrobenzene is reacted with chlorosulphonic acid at approximately 90 to approximately 120 �C and an inorganic acid chloride i...
|
|
WO/1991/012237A1 |
A novel benzenesulfonamide derivative of formula (I) which has an action of inhibiting phospholipase A2 and therefore is effective in treating diseases for which this action is used to advantage.
|
|
WO/1991/011994A1 |
A pharmaceutical composition containing as the active ingredient a compound which presents low-density lipoproteins (LDL) represented by the compounds of formula (I) from being negatively charged. This composition inhibits the LDL from u...
|
|
WO/1991/011504A1 |
New anionic tensides may be obtained by sulphitation of hydroxycarboxylic acid esters, followed by neutralisation with aqueous bases, and are useful as surface-active substances.
|
|
WO/1991/010642A1 |
The present invention relates to a process for preparing S- and R-enantiomers of certain substituted 3-aryloxy-2-hydroxypropylamines used as beta blockers, and to the S- and R-enantiomers of certain intermediates used for this preparativ...
|
|
WO/1991/009009A1 |
Aqueous solutions of alkaline, alkaline earth, ammonium and/or amine salts of sulphonated fatty acid glycerine esters are obtained by converting fatty acid glycerine esters with iodine numbers lower than 5 with gaseous sulphur trioxide i...
|
|
WO/1991/008265A1 |
The description relates to azo compounds corresponding to formula (1) below, having fibre-reactive properties and making valuable dyes. They can dye hydroxy and/or carbonamide group-containing synthetic and natural materials, especially ...
|
